AzTrials
AzTrials

Pain PostoperativeAA-CSNCT07322601

Supportive Analgesic Effect of Auricular Acupressure (AA) After Cesarean Section (CS)

A study testing Auricular Acupressure in people with Pain Postoperative and Caesarean Section; Pain, run by University of Medicine and Pharmacy at Ho Chi Minh City at 1 site in Vietnam.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Introduction: Severe acute pain after cesarean section is an independent risk factor for the development of chronic pain and increases the risk of postpartum depression threefold. Pain also reduces the mother's ability to breastfeed and care for her child. Read more about this study

Who is it for?
Ages 18 to 40 years, women only
Conditions the study is for
Pain Postoperative, Caesarean Section; Pain
What is being tested?
Auricular Acupressure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
70 participants
Where
1 siteVietnam
Study dates
14 Oct 2024to 30 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • 18-40 years of age
  • Gestational age ≥ 37 weeks
  • Alert and cooperative with the treating physicians
  • Able to understand and use the Visual Analog Scale (VAS)
  • Preoperative American Society of Anesthesiologists (ASA) Physical Status Classification System I-II
  • Anesthesia: spinal anesthesia;
Show all 11Show fewer
  • Pfannenstiel suprapubic transverse incision
  • Infant 5-minute Appearance, Pulse, Grimace, Activity, Respiration score (Apgar score) > 7
  • Cesarean operative time ≤ 60 minutes
  • Singleton pregnancy
  • Voluntary agreement to participate.

Who cannot join

  • Contraindication to diclofenac
  • Surgical complications, including hysterectomy and postpartum hemorrhage (> 1000 ml)
  • History of acupuncture syncope
  • Preoperative chronic pain and/or regular preoperative use of analgesics
  • Addiction to or dependence on opioids or alcohol
  • Diabetes mellitus or HIV infection
Show all 9Show fewer
  • Prior Auricular acupressure
  • Skin lesions of the auricle
  • Surgical wound infection

Trial locations and contacts

1 site in 1 country.

Vietnam1 site
  • Le Van Thinh Hospital

    Ho Chi Minh City, Binh Trung Ward

Other trials in Vietnam

About this study

Official title: Evaluation of the Supportive Analgesic Effect of Auricular Acupressure After Cesarean Section: A Randomized Clinical Controlled Trial

Introduction:

Severe acute pain after cesarean section is an independent risk factor for the development of chronic pain and increases the risk of postpartum depression threefold. Pain also reduces the mother's ability to breastfeed and care for her child. This study aimed to evaluate the supportive effectiveness of auricular acupressure in reducing incision pain and uterine contraction pain in women undergoing cesarean section, compared with sham auricular acupressure.

Read more

Methods:

A randomized, controlled, single-blind clinical trial was conducted in seventy women undergoing cesarean section, randomly allocated (1:1) to an auricular acupressure or sham group. The study group received vaccaria seeds, and the sham group received non-vaccaria patches on both ears. Both groups were treated at the Shenmen, Lung, Internal Genitalia, Pelvis, Subcortex, and Sympathetic points. Pain was assessed using the Visual Analog Scale (VAS), and diclofenac consumption was recorded over the first 48 hours postpartum.

Read the detailed description

Participants are instructed to apply pressure to the patches three times daily (morning, noon, and evening). Supplemental acupressure is also performed whenever the participant feels pain, with the goal of achieving the 'De-qi' sensation (a feeling of soreness or tingling). All patches are maintained for 48 hours. Postoperative analgesia follows a standardized hospital protocol, with diclofenac administered as rescue medication.

Safety monitoring is strictly implemented throughout the study. If participants experience symptoms such as headache, dizziness, or syncope following the application of auricular patches, they will be managed according to standardized acupuncture safety protocols. Participants will be withdrawn from the study if they develop adverse reactions, including local allergic reactions at the patch site, persistent local pain, or severe dizziness.

Being tested
Auricular Acupressure, Sham Auricular Acupressure Group
Medical subject headings
Pain, Postoperative, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Auricular AcupressureOther

    Also called Auricular Acupuncture, Acupuncture

    In the Auricular Acupressure group, participants received auricular acupressure using vaccaria seeds applied to the following points on both ears: Ear Shenmen (TF4), Lung (CO14), Internal Genitalia (TF2), Pelvis (TF5), Subcortex (AT4), and Sympathetic (AH6), in addition to standard postoperative care.

    Each participant received a single treatment session within 5 hours after cesarean section, once transferred to the Obstetrics Department. Seeds were retained for 2 days. All acupuncture procedures were performed by licensed traditional medicine physicians who had been trained and standardized before the study.

  • Sham Auricular Acupressure GroupOther

    Also called Sham Acupuncture, Sham Auricular Acupuncture

    In the Sham Auricular Acupressure Group, participants received adhesive patches without seeds, identical in size and appearance to the Auricular Acupressure Group patches, applied to the same auricular points. Both groups received standard postoperative care.

Study groups in NCT07322601
Study groupRoleWhat they receive
Auricular Acupressure GroupExperimentalParticipants received auricular acupressure using Vaccaria seeds applied to Shenmen [Antitragus-4 (TF4)], Lung [Concha-14 (CO14)], Internal Genitalia [Triangular fossa-2 (TF2)], Pelvis [Triangular fossa-5 (TF5)], Subcortex [Antitragus-4 (AT4)], and Sympathetic [Antihelix-6 (AH6)].
Receives: Other: Auricular Acupressure
Sham Auricular Acupressure GroupSham comparatorParticipants received identical adhesive patches without seeds applied to the same auricular points.
Receives: Other: Sham Auricular Acupressure Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain relief effectiveness was assessed using the Visual Analog Scale (VAS) for pain intensity at rest, during movement and for uterine contractions at 12, 24, and 48 hours after cesarean section.

    Pain relief effectiveness was assessed using the Visual Analog Scale (VAS) for pain intensity at rest, during movement and for uterine contractions at 12, 24, and 48 hours after cesarean section. The Visual Analog Scale (VAS) consists of a line where respondents are asked to mark their level of pain. The left-most point (zero) represents no pain and the right-most point (10) represents extreme pain. The higher the score, the more severe the pain.

    Measured: 12, 24, 48 hours postoperative

  2. VAS scores for pain intensity at rest, pain intensity on movement, and uterine contraction pain

    Pain relief effectiveness was assessed using the Visual Analog Scale (VAS) for pain intensity at rest, during movement and for uterine contractions at 12, 24, and 48 hours after cesarean section. The Visual Analog Scale (VAS) consists of a line where respondents are asked to mark their level of pain. The left-most point (0) represents 'no pain,' while the right-most point (10) represents 'extreme pain.' The higher the score, the more severe the pain.

    Measured: From enrollment to the end of treatment at 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2026
  2. Study start14 Oct 2024
  3. Primary completion30 Jun 2025
  4. Study completion30 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomly assigned to the auricular acupressure group or sham auricular acupressure group in a 1:1 ratio.
Masking
Single blind
Who is masked
Participant
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07322601
Sponsor's protocol ID
3962/DHYD-HDDD
Acronym
AA-CS
Status last verified
Oct 2025
First submitted
14 Dec 2025
Last updated
7 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The type of data set or supporting information being shared. Options include: study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code.

Questions about this trial

What is this clinical trial studying?

A study testing Auricular Acupressure in people with Pain Postoperative and Caesarean Section; Pain, run by University of Medicine and Pharmacy at Ho Chi Minh City at 1 site in Vietnam.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Vietnam. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain relief effectiveness was assessed using the Visual Analog Scale (VAS) for pain intensity at rest, during movement and for uterine contractions at 12, 24, and 48 hours after cesarean section. (time frame: 12, 24, 48 hours postoperative). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in